About the Authors

Thierry Buclin

thierry.buclin@chuv.ch

Affiliations Division of Clinical Pharmacology and Toxicology, University Hospital Center and University of Lausanne, Lausanne, Switzerland, Department of Primary Health Care, Centre for Evidence-Based Medicine, University of Oxford, Oxford, United Kingdom

Amalio Telenti

Affiliation Microbiology Institute and Swiss HIV Cohort Study board, University Hospital Center and University of Lausanne, Lausanne, Switzerland

Rafael Perera

Affiliation Department of Primary Health Care, Centre for Evidence-Based Medicine, University of Oxford, Oxford, United Kingdom

Chantal Csajka

Affiliations Division of Clinical Pharmacology and Toxicology, University Hospital Center and University of Lausanne, Lausanne, Switzerland, Clinical Pharmacy Unit, Department of Pharmaceutical Sciences, University of Geneva and Lausanne, Lausanne, Switzerland

Hansjakob Furrer

Affiliation University Clinic for Infectious Diseases and Swiss HIV Cohort Study Board, University Hospital and University of Bern, Bern, Switzerland

Jeffrey K. Aronson

Affiliation Department of Primary Health Care, Centre for Evidence-Based Medicine, University of Oxford, Oxford, United Kingdom

Paul P. Glasziou

Affiliation Department of Primary Health Care, Centre for Evidence-Based Medicine, University of Oxford, Oxford, United Kingdom

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

Conceived and designed the experiments: TB AT CC. Performed the experiments: TB PG. Analyzed the data: TB PG RP. Contributed reagents/materials/analysis tools: AT HF. Wrote the paper: TB JA PG. Logistic support: PG RP.